Wassim Abida
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 63
- Prostate Cancer Diagnosis and Treatment 8
- Oncology 47
- PARP inhibition in cancer therapy 33
- Co-authors
- Wei Gu (2 shared papers)Howard I. Scher (32 shared papers)Nikolaus Schultz (14 shared papers)Charles L. Sawyers (10 shared papers)Wenzhu Zhang (1 shared paper)Wenhui Zhao (1 shared paper)Anatoly Nikolaev (1 shared paper)Michael J. Morris (21 shared papers)
- Journals
- Journal of Clinical Oncology (34 papers)Annals of Oncology (11 papers)Cancer Research (5 papers)Clinical Cancer Research (4 papers)European Urology Oncology (3 papers)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Wassim Abida
85 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 583
- Pulmonary and Respiratory Medicine 945
- Oncology 785
- Molecular Biology 1.0k
- Immunology 138
Countries citing papers authored by Wassim Abida
This map shows the geographic impact of Wassim Abida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wassim Abida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wassim Abida more than expected).
Fields of papers citing papers by Wassim Abida
This network shows the impact of papers produced by Wassim Abida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wassim Abida. The network helps show where Wassim Abida may publish in the future.
Co-authors
The 25 scholars most cited alongside Wassim Abida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 191 | |
| 2 | 2020 | 170 | |
| 3 | 2006 | 162 | |
| 4 | 2017 | 136 | |
| 5 | 2020 | 119 | |
| 6 | 2020 | 98 | |
| 7 | 2020 | 97 | |
| 8 | 2008 | 86 | |
| 9 | 2020 | 76 | |
| 10 | 2000 | 73 | |
| 11 | 2019 | 69 | |
| 12 | 2017 | 57 | |
| 13 | 2016 | 42 | |
| 14 | 2018 | 40 | |
| 15 | 2019 | 27 | |
| 16 | 2018 | 27 | |
| 17 | 2022 | 26 | |
| 18 | 2002 | 26 | |
| 19 | 2018 | 22 | |
| 20 | 2021 | 21 |
About Wassim Abida
Wassim Abida is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 93 papers that have together received 1.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (63 papers), PARP inhibition in cancer therapy (33 papers), Cancer Genomics and Diagnostics (20 papers), DNA Repair Mechanisms (12 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Protein Degradation and Inhibitors (8 papers), Cancer, Lipids, and Metabolism (8 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Cancer Research (583 citations), Pulmonary and Respiratory Medicine (945 citations), Oncology (785 citations), Molecular Biology (1.0k citations) and Immunology (138 citations). Wassim Abida has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Wei Gu, Howard I. Scher, Nikolaus Schultz, Charles L. Sawyers, Wenzhu Zhang, Wenhui Zhao, Anatoly Nikolaev, Michael J. Morris, David B. Solit and Hening Lin. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Clinical Cancer Research and European Urology Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.